Titan Pharmaceuticals
TTNP
#10414
Rank
S$7.94 M
Marketcap
S$5.97
Share price
-3.76%
Change (1 day)
19.65%
Change (1 year)

Titan Pharmaceuticals (TTNP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$0.34 Million

According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.34 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.65 M-65.57%
2023-12-31S$1.9 M-47.21%
2022-12-31S$3.61 M-6.43%
2021-12-31S$3.86 M-35.93%
2020-12-31S$6.02 M-44.74%
2019-12-31S$10.9 M9.89%
2018-12-31S$9.92 M-7.81%
2017-12-31S$10.76 M35.82%
2016-12-31S$7.92 M-11.02%
2015-12-31S$8.9 M-44.93%
2014-12-31S$16.17 M0.81%
2013-12-31S$16.04 M-72.64%
2012-12-31S$58.64 M49.47%
2011-12-31S$39.23 M181.9%
2010-12-31S$13.91 M152.07%
2009-12-31S$5.52 M
2007-12-31S$6.12 M17.68%
2006-12-31S$5.2 M-0.33%
2005-12-31S$5.22 M-12.84%
2004-12-31S$5.99 M5.53%
2003-12-31S$5.67 M-17.07%
2002-12-31S$6.84 M-35.85%
2001-12-31S$10.67 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vanda Pharmaceuticals
VNDA
S$0.17 B 51,284.41%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
S$3.84 M 1,028.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$64.89 M 18,940.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$147.13 B 43,170,622.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$81.04 B 23,778,227.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
S$1.08 B 319,528.90%๐Ÿ‡บ๐Ÿ‡ธ USA